226 related articles for article (PubMed ID: 32891904)
41. [The correlation between coagulation function and prognosis in patients with acute respiratory distress syndrome caused by extrapulmonary sepsis or pulmonary infection].
Yu SH; Ma YT; Li X
Zhonghua Nei Ke Za Zhi; 2021 Jul; 60(7):650-655. PubMed ID: 34619843
[No Abstract] [Full Text] [Related]
42. ARDS in solid organ transplant recipients hospitalized for COVID-19 based on the 2023 new definition.
Tang J; Zhou Y; Gong L; Deng J; Yuan Y; Zhong Y; Li J; Wang G
Heart Lung; 2024; 66():103-107. PubMed ID: 38604053
[TBL] [Abstract][Full Text] [Related]
43. Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.
Li J; Wei J; Xu Z; Jiang C; Li M; Chen J; Li Y; Yang M; Gu Y; Wang F; Shu Y; Yang Y; Sun L; Liu Y
Front Immunol; 2021; 12():691879. PubMed ID: 34163488
[TBL] [Abstract][Full Text] [Related]
44. Neutrophil elastase inhibitor (sivelestat) may be a promising therapeutic option for management of acute lung injury/acute respiratory distress syndrome or disseminated intravascular coagulation in COVID-19.
Sahebnasagh A; Saghafi F; Safdari M; Khataminia M; Sadremomtaz A; Talaei Z; Rezai Ghaleno H; Bagheri M; Habtemariam S; Avan R
J Clin Pharm Ther; 2020 Dec; 45(6):1515-1519. PubMed ID: 32860252
[TBL] [Abstract][Full Text] [Related]
45. [Pathogenesis, diagnosis, prevention and treatment of disseminated intravascular coagulation syndrome in COVID-19 infection].
Vorobyev PA; Momot AP; Krasnova LS; Vorobiev AP; Talipov AK
Ter Arkh; 2020 Dec; 92(11):51-56. PubMed ID: 33720604
[TBL] [Abstract][Full Text] [Related]
46. Pathomechanisms Underlying Hypoxemia in Two COVID-19-Associated Acute Respiratory Distress Syndrome Phenotypes: Insights From Thrombosis and Hemostasis.
Gando S; Wada T
Shock; 2022 Jan; 57(1):1-6. PubMed ID: 34172612
[TBL] [Abstract][Full Text] [Related]
47. Potential mechanisms of nafamostat therapy for severe COVID-19 pneumonia with disseminated intravascular coagulation.
Takahashi W; Yoneda T; Koba H; Ueda T; Tsuji N; Ogawa H; Asakura H
Int J Infect Dis; 2021 Jan; 102():529-531. PubMed ID: 33157292
[TBL] [Abstract][Full Text] [Related]
48. Mucins carrying selectin ligands as predictive biomarkers of disseminated intravascular coagulation complication in ARDS.
Nakashima T; Yokoyama A; Inata J; Ishikawa N; Haruta Y; Hattori N; Kohno N
Chest; 2011 Feb; 139(2):296-304. PubMed ID: 20671055
[TBL] [Abstract][Full Text] [Related]
49. The CHARTER-Ireland trial: can nebulised heparin reduce acute lung injury in patients with SARS-CoV-2 requiring advanced respiratory support in Ireland: a study protocol and statistical analysis plan for a randomised control trial.
Sheehan JR; Calpin P; Kernan M; Kelly C; Casey S; Murphy D; Alvarez-Iglesias A; Giacomini C; Cody C; Curley G; McGeary S; Hanley C; McNicholas B; van Haren F; Laffey JG; Cosgrave D
Trials; 2022 Sep; 23(1):774. PubMed ID: 36104785
[TBL] [Abstract][Full Text] [Related]
50. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
51. COVID-19 versus Non-COVID-19 Acute Respiratory Distress Syndrome: Comparison of Demographics, Physiologic Parameters, Inflammatory Biomarkers, and Clinical Outcomes.
Bain W; Yang H; Shah FA; Suber T; Drohan C; Al-Yousif N; DeSensi RS; Bensen N; Schaefer C; Rosborough BR; Somasundaram A; Workman CJ; Lampenfeld C; Cillo AR; Cardello C; Shan F; Bruno TC; Vignali DAA; Ray P; Ray A; Zhang Y; Lee JS; Methé B; McVerry BJ; Morris A; Kitsios GD
Ann Am Thorac Soc; 2021 Jul; 18(7):1202-1210. PubMed ID: 33544045
[No Abstract] [Full Text] [Related]
52. Continuous renal replacement therapy with the addition of CytoSorb cartridge in critically ill patients with COVID-19 plus acute kidney injury: A case-series.
Alharthy A; Faqihi F; Memish ZA; Balhamar A; Nasim N; Shahzad A; Tamim H; Alqahtani SA; Brindley PG; Karakitsos D
Artif Organs; 2021 May; 45(5):E101-E112. PubMed ID: 33190288
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia.
Pavoni V; Gianesello L; Pazzi M; Stera C; Meconi T; Frigieri FC
J Thromb Thrombolysis; 2020 Aug; 50(2):281-286. PubMed ID: 32394236
[TBL] [Abstract][Full Text] [Related]
54. COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure.
Spiezia L; Boscolo A; Poletto F; Cerruti L; Tiberio I; Campello E; Navalesi P; Simioni P
Thromb Haemost; 2020 Jun; 120(6):998-1000. PubMed ID: 32316063
[TBL] [Abstract][Full Text] [Related]
55. Recombinant human thrombomodulin for pneumonia-induced severe ARDS complicated by DIC in children: a preliminary study.
Hirata N; Ngo DT; Phan PH; Ainai A; Phung TTB; Ta TA; Takasaki J; Kawachi S; Nunoi H; Nakajima N; Dien TM
J Anesth; 2021 Oct; 35(5):638-645. PubMed ID: 34259911
[TBL] [Abstract][Full Text] [Related]
56. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.
Wang Z; Wang Z
BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706
[TBL] [Abstract][Full Text] [Related]
57. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
Yang X; Yu Y; Xu J; Shu H; Xia J; Liu H; Wu Y; Zhang L; Yu Z; Fang M; Yu T; Wang Y; Pan S; Zou X; Yuan S; Shang Y
Lancet Respir Med; 2020 May; 8(5):475-481. PubMed ID: 32105632
[TBL] [Abstract][Full Text] [Related]
58. Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study.
Heubner L; Greiner M; Vicent O; Beyer-Westendorf J; Tiebel O; Scholz U; Güldner A; Mirus M; Fries D; Koch T; Spieth PM
Thromb J; 2022 Aug; 20(1):48. PubMed ID: 36038895
[TBL] [Abstract][Full Text] [Related]
59. Rotational thromboelastometry (ROTEM) profiling of COVID-19 patients.
Mitrovic M; Sabljic N; Cvetkovic Z; Pantic N; Zivkovic Dakic A; Bukumiric Z; Libek V; Savic N; Milenkovic B; Virijevic M; Vucinic V; Milosevic I; Pravdic Z; Suvajdzic N; Fareed J; Antic D
Platelets; 2021 Jul; 32(5):690-696. PubMed ID: 33561381
[TBL] [Abstract][Full Text] [Related]
60. The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS.
Dreher M; Kersten A; Bickenbach J; Balfanz P; Hartmann B; Cornelissen C; Daher A; Stöhr R; Kleines M; Lemmen SW; Brokmann JC; Müller T; Müller-Wieland D; Marx G; Marx N
Dtsch Arztebl Int; 2020 Apr; 117(16):271-278. PubMed ID: 32519944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
